Criteria for return to work for healthcare personnel with confirmed or suspected COVID-19 (interim guidance)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Criteria for return to work for healthcare personnel with confirmed or suspected COVID-19 (interim guidance)

Filetype[PDF-203.13 KB]


English

Details:

  • Corporate Authors:
  • Description:
    Updated Aug. 10, 2020

    Summary of Recent Changes as of August 10, 2020 to more closely align guidance with Decision Memo:

    • For HCP with severe to critical illness or who are severely immunocompromised1, the recommended duration for work exclusion was changed to at least 10 days and up to 20 days after symptom onset.

    • Recommendation to consider consultation with infection control experts.

    • Added example applying disease severity in determining duration before return to work.

    • Added hematopoietic stem cell or solid organ transplant to severely immunocompromised conditions.

    Who this is for: Occupational health programs and public health officials making decisions about return to work for healthcare personnel (HCP) with confirmed SARS-CoV-2 infection, or who have suspected SARS-CoV-2 infection (e.g., developed symptoms of COVID-19) but were never tested for SARS-CoV-2.

    HCP with symptoms of COVID-19 should be prioritized for viral testing with approved nucleic acid or antigen detection assays. When a clinician decides that testing a person for SARS-CoV-2 is indicated, negative results from at least one FDA Emergency Use Authorized COVID-19 molecular viral assay for detection of SARS-CoV-2 RNA indicates that the person most likely does not have an active SARS-CoV-2 infection at the time the sample was collected. A second test for SARS-CoV-2 RNA may be performed at the discretion of the evaluating healthcare provider, particularly when a higher level of clinical suspicion for SARS-CoV-2 infection exists. For HCP who were suspected of having COVID-19 and had it ruled out, either with at least one negative test or a clinical decision that COVID-19 is not suspected and testing is not indicated, then return to work decisions should be based on their other suspected or confirmed diagnoses.

    Decisions about return to work for HCP with SARS-CoV-2 infection should be made in the context of local circumstances. In general, a symptom-based strategy should be used as described below. The time period used depends on the HCP’s severity of illness and if they are severely immunocompromised.

  • Content Notes:
    Return to Work Criteria for HCP with Confirmed or Suspected COVID-19 -- Return to Work Practices and Work Restrictions -- Strategies to Mitigate Healthcare Personnel Staffing Shortages.
  • Subjects:
  • Series:
  • Document Type:
  • Genre:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

More +

You May Also Like

Checkout today's featured content at stacks.cdc.gov